Form 8-K - Current report:
SEC Accession No. 0001493152-22-027872
Filing Date
2022-10-07
Accepted
2022-10-07 08:59:18
Documents
15
Period of Report
2022-10-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 50486
2 ex10-1.htm EX-10.1 137190
3 ex99-1.htm EX-99.1 14151
4 ex99-1_001.jpg GRAPHIC 12057
  Complete submission text file 0001493152-22-027872.txt   427311

Data Files

Seq Description Document Type Size
5 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mbot-20221006.xsd EX-101.SCH 3248
6 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mbot-20221006_lab.xml EX-101.LAB 34240
7 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mbot-20221006_pre.xml EX-101.PRE 22373
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3600
Mailing Address 25 RECREATION PARK DR SUITE 108 HINGHAM MA 02043
Business Address 25 RECREATION PARK DR SUITE 108 HINGHAM MA 02043 908-938-5561
Microbot Medical Inc. (Filer) CIK: 0000883975 (see all company filings)

EIN.: 943078125 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19871 | Film No.: 221299392
SIC: 2836 Biological Products, (No Diagnostic Substances)